selegiline has been researched along with Hallucinations in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hayashi, R; Kohsaka, M; Oeda, T; Sawada, H; Sudoh, S; Sugiyama, H; Tomita, S; Umemura, A; Yamamoto, K | 1 |
| Kato, S; Kobayashi, T; Saito, N; Shioda, K; Suda, S | 1 |
| Hirata, A; Kaida, K; Kamakura, K; Kanzaki, M; Masaki, T; Mochizuki, H; Motoyoshi, K; Nakamura, R | 1 |
| Argyriou, AA; Papapetropoulos, S | 1 |
| Standaert, DG; Stern, MB | 1 |
| Ghaemi, M; Rudolf, J; Schmülling, S | 1 |
1 review(s) available for selegiline and Hallucinations
| Article | Year |
|---|---|
Update on the management of Parkinson's disease.
Topics: Depression; Diagnosis, Differential; Dopamine Agents; Hallucinations; Humans; Levodopa; Parkinson Disease; Selegiline | 1993 |
5 other study(ies) available for selegiline and Hallucinations
| Article | Year |
|---|---|
Subclinical elevation of plasma C-reactive protein and illusions/hallucinations in subjects with Parkinson's disease: case-control study.
Topics: Amantadine; C-Reactive Protein; Case-Control Studies; Cross-Sectional Studies; Delusions; Dopamine Agents; Hallucinations; Humans; Illusions; Levodopa; Logistic Models; Multivariate Analysis; Parkinson Disease; Psychotic Disorders; Risk Factors; Selegiline; Surveys and Questionnaires | 2014 |
Pharmacoresistant convulsions and visual hallucinations around two weeks after selegiline overdose: a case report.
Topics: Anticonvulsants; Bipolar Disorder; Coma; Diazepam; Drug Overdose; Drug Resistance; Hallucinations; Humans; Male; Middle Aged; Monoamine Oxidase Inhibitors; Phenytoin; Seizures; Selegiline; Suicide, Attempted | 2011 |
Therapeutic factors causing hallucination in Parkinson's disease patients, especially those given selegiline.
Topics: Adult; Aged; Aged, 80 and over; Chi-Square Distribution; Female; Hallucinations; Humans; Male; Middle Aged; Parkinson Disease; Retrospective Studies; Selegiline; Statistics, Nonparametric | 2004 |
Administration of selegiline is not associated with visual hallucinations in advanced Parkinson's disease patients.
Topics: Antiparkinson Agents; Hallucinations; Humans; Parkinson Disease; Selegiline | 2005 |
Deterioration of parkinsonian symptoms following treatment of dopaminergic hallucinosis with olanzapine.
Topics: Aged; Antiparkinson Agents; Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Clozapine; Drug Therapy, Combination; Hallucinations; Humans; Levodopa; Male; Olanzapine; Paranoid Disorders; Parkinson Disease; Piperidines; Pirenzepine; Selegiline; Severity of Illness Index | 1999 |